The Fc (fragment crystallizable) region of immunoglobulin G, while not binding antigen, contains crucial biological activities and antigenic determinants. This homodimeric glycoprotein comprises CH2 and CH3 domains and mediates immune effector functions through interactions with Fc receptors, C1q, and FcRn.
Fc fragments orchestrate antibody-dependent cellular cytotoxicity, complement-dependent cytotoxicity, and phagocytosis while controlling IgG's serum half-life via pH-dependent FcRn binding. The conserved N-linked glycosylation at Asn-297 is essential for structural stability and receptor interactions.
Altered Fc glycosylation patterns correlate with autoimmune conditions including rheumatoid arthritis, where reduced galactosylation and sialylation indicate inflammatory disease states. Fc receptor polymorphisms are also associated with autoimmune disease development.
Common uses include therapeutics research, immune system research, flow cytometry assays, antisera production.
GHS06, GHS08, GHS09
Danger
H300+H310+H330, H373, H400, H410
12 - Non Combustible Liquids
Acute Tox. 2; Acute Tox. 1; STOT RE2; Aquatic Acute 1; Aquatic Chronic 1
P301+P316, P302+P352, P304+P340, P316, P319, P361+P364, P391, P403+P233, P501